Cargando…

Effect of Combined Perftoran and Indocyanine Green-Photodynamic Therapy on HypoxamiRs and OncomiRs in Lung Cancer Cells

Indocyanine green (ICG) is a nontoxic registered photosensitizer used as a diagnostic tool and for photodynamic therapy (PDT). Hypoxia is one the main factors affecting PDT efficacy. Perfluorodecalin emulsion (Perftoran(®)) is a known oxygen carrier. This study investigated the effect of Perftoran(®...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gamal-Eldeen, Amira M., Alrehaili, Amani A., Alharthi, Afaf, Raafat, Bassem M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966667/ https://www.ncbi.nlm.nih.gov/pubmed/35370727 http://dx.doi.org/10.3389/fphar.2022.844104

Ejemplares similares

Perftoran( ® ) Inhibits Hypoxia-Associated Resistance in Lung Cancer Cells to Carboplatin
por: Gamal-Eldeen, Amira M., et al.
Publicado: (2022)

Diagnostic Potential of Exosomal HypoxamiRs in the Context of Hypoxia–Sumoylation–HypoxamiRs in Early Onset Preeclampsia at the Preclinical Stage
por: Gusar, Vladislava, et al.
Publicado: (2022)

OncomiRs: the discovery and progress of microRNAs in cancers
por: Cho, William CS
Publicado: (2007)

Differential Expression of miRNAs in Hypoxia (“HypoxamiRs”) in Three Canine High-Grade Glioma Cell Lines
por: Koehler, Jennifer, et al.
Publicado: (2020)

Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017)

MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
por: Banno, Kouji, et al.
Publicado: (2014)

Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy
por: Wang, Yazhe, et al.
Publicado: (2023)

HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
por: Salinas-Vera, Yarely M., et al.
Publicado: (2019)

HypoxamiR-210 accelerates wound healing in diabetic mice by improving cellular metabolism
por: Narayanan, Sampath, et al.
Publicado: (2020)

Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells
por: Salinas-Vera, Yarely M., et al.
Publicado: (2020)

OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications
por: Otmani, Khalid, et al.
Publicado: (2022)

Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
por: Das, Ani V., et al.
Publicado: (2015)

Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma
por: Nadda, Neeti, et al.
Publicado: (2021)

OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018)

BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control
por: Stefansson, Olafur Andri, et al.
Publicado: (2012)

Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development
por: Bollati, Valentina, et al.
Publicado: (2023)

Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer
por: Dhar, Swati, et al.
Publicado: (2015)

Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma
por: Liu, Chia-Hsin, et al.
Publicado: (2022)

Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
por: Barnaś, Edyta, et al.
Publicado: (2023)

OncomiR-17-5p: alarm signal in cancer?
por: Bobbili, Madhusudhan Reddy, et al.
Publicado: (2017)

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1
por: Boces-Pascual, Clara, et al.
Publicado: (2021)

A structural map of oncomiR-1 at single-nucleotide resolution
por: Chakraborty, Saikat, et al.
Publicado: (2017)

Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
por: Gilles, Maud-Emmanuelle, et al.
Publicado: (2019)

miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2016)

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
por: Monroig-Bosque, Paloma del C., et al.
Publicado: (2018)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019)

Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?
por: Jeang, Kuan-Teh
Publicado: (2010)

miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
por: Liu, Yanqing, et al.
Publicado: (2016)

OncomiR Addiction Is Generated by a miR-155 Feedback Loop in Theileria-Transformed Leukocytes
por: Marsolier, Justine, et al.
Publicado: (2013)

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression
por: de Melo Maia, Beatriz, et al.
Publicado: (2016)

Author Correction: miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2021)

EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas
por: Nourmohammadi, Fatemeh, et al.
Publicado: (2022)

miR-3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression
por: Yang, Xiu-Hua, et al.
Publicado: (2018)

C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
por: Di Pascale, Federica, et al.
Publicado: (2018)

Anti-hypoxic Effect of Polysaccharide Extract of Brown Seaweed Sargassum dentifolium in Tongue Squamous Cell Carcinoma
por: Gamal-Eldeen, Amira M., et al.
Publicado: (2022)

Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma
por: Janiszewska, Joanna, et al.
Publicado: (2015)

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients
por: Mavridis, K, et al.
Publicado: (2015)

miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis
por: Seashols-Williams, S. J., et al.
Publicado: (2016)

The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b
por: Ma, Qiang, et al.
Publicado: (2015)

Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis
por: Budd, William T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g72t77nuubm9t64b43h2qftacu